Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Ostroleka

3 clinical trials in Ostroleka, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Ostroleka at a glance
3
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Ostroleka

Open in trial search

Arteriosclerosis

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Novartis Pharma AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Doxorubicin
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Ostroleka

What the registry says about research in the country

01 Breast Cancer Research

Innovative clinical trials focusing on hormone receptor-positive (HR+) and HER2-negative breast cancer treatments, combining established endocrine therapies with novel approaches.

  • Early-stage breast cancer interventions
  • Neoadjuvant therapy evaluation
  • Endocrine therapy combinations

Studies aim to improve survival rates and treatment effectiveness for breast cancer patients through targeted therapeutic approaches.

02 Cardiovascular Medicine

Research targeting atherosclerotic cardiovascular disease (ASCVD) with innovative therapeutic approaches to prevent major adverse cardiovascular events.

  • Cardiovascular death prevention
  • Heart attack risk reduction
  • Stroke prevention strategies

Clinical investigations focus on reducing cardiovascular risks in patients with established vascular disease using novel medical interventions.

03 Urological Oncology

Advanced research into muscle-invasive bladder cancer treatment, exploring combination therapies with both neoadjuvant and adjuvant approaches.

  • Bladder cancer therapy
  • Combination treatment protocols
  • Immunotherapy applications

Studies evaluate innovative treatment combinations to improve outcomes for patients with invasive bladder cancer.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.